News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
Among the study's goals is to identify molecular signatures that can distinguish idiopathic pulmonary fibrosis from interstitial lung disease.
A CFTR gene mutation found in 90 percent of US cystic fibrosis patients was only present in a third of Puerto Rican and 10 percent of Dominican patients.
A new partnership and licensing agreement will help the research institute aggregate genotype and phenotype data for the NIH-funded PreCISE Network asthma program.
The drug developer said that the biomarker panel will form the basis of a planned point-of-care test for acute respiratory distress syndrome.
Stakeholders discussed last year's decision by Palmetto to deny coverage for large respiratory panels and discussed the way forward for test developers and labs.
